COYOTE
Company

Last deal

$7.4M
Local Amount - CNY 50.M

Amount

Series E

Stage

28.03.2019

Date

5

all rounds

$36.5M

Total amount

General

About Company
Coyote Bioscience develops genetic molecular diagnostic technology for healthcare solutions.

Industry

Sector :

Subsector :

Keywords :

Also Known As

卡尤迪生物, 卡尤迪生物科技(北京)有限公司, Kayoudi Shengwu

founded date

04.12.2009

Number of employees

Company Type

For Profit

Last funding type

Series E

IPO status

Private

Description

The company specializes in creating clinical diagnostic devices, reagents, and detection systems for rapid screening of infectious diseases, personalized medication guidance, and monitoring intestinal microbes in infants and young children. Coyote Bioscience is committed to making molecular diagnostics portable and accessible at the point of care, with a focus on pathogen detection and life science tools. Their molecular diagnostic information provides users with customized health management solutions.
Contacts